Patents by Inventor Sofia Forssten
Sofia Forssten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250375485Abstract: Provided herein, inter alia, are compositions comprising one or more biologically pure strains of bacteria as well as methods of making and using the same to treat and/or prevent one or more obesity related disorders in a subject in need thereof.Type: ApplicationFiled: April 24, 2025Publication date: December 11, 2025Inventors: Sofia FORSSTEN, Oliver HASSELWANDER, Ashley Ann HIBBERD, Henrik Max JENSEN, Helene M A KANE, Hye-Sook KIM, Ritesh KUMAR, Arthur OUWEHAND, Pia Tuulikki RASINKANGAS, Pierre E ROUVIERE, Buffy L STAHL, Qiong WANG
-
Publication number: 20250375490Abstract: Bacteria and metabolites thereof that are capable of binding to A, B or O blood type antigens or combinations thereof or which are acid or bile tolerant or both, their use in probiotic compositions and food products, and methods for their selection are disclosed. Methods using said bacteria and metabolites for the prevention or treatment of gastrointestinal disorders or both are also disclosed.Type: ApplicationFiled: August 14, 2025Publication date: December 11, 2025Inventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Janne Nikkilä
-
Patent number: 12433921Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to vaginal cells and producing hydrogen peroxide, their use in probiotic compositions and food products and methods for their selection. The invention also relates to the use of said bacteria, metabolites and probiotic compositions for the prevention and/or treatment of urogenital disorders.Type: GrantFiled: January 19, 2022Date of Patent: October 7, 2025Assignee: INTERNATIONAL N&H DENMARK APSInventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Inger Mattsby-Baltzer, Björn Andersch
-
Patent number: 12419923Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to A, B and/or O blood type antigens or which are acid and/or bile tolerant, their use in probiotic compositions and food products, and methods for their selection. The invention also relates to the use of said bacteria and metabolites for the prevention and/or treatment of gastrointestinal disorders.Type: GrantFiled: August 2, 2023Date of Patent: September 23, 2025Assignee: INTERNATIONAL N&HDENMARK APSInventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Janne Nikkilä
-
Publication number: 20250017981Abstract: Provided herein, inter alia, are compositions comprising one or more biologically pure strains of bacteria as well as methods of making and using the same to treat and/or prevent one or more obesity related disorders in a subject in need thereof.Type: ApplicationFiled: November 22, 2022Publication date: January 16, 2025Inventors: Ritesh Kumar, Helene Kane, Qiong Wang, Henrik Max Jensen, Pia Tuulikki Rasinkangas, Arthur Ouwehand, Ashley Hibberd, Buffy Stahl, Sofia Forssten, Oliver Hasselwander, Hye-Sook Kim, Pierre Rouviere
-
Publication number: 20240245735Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to A, B and/or O blood type antigens or which are acid and/or bile tolerant, their use in probiotic compositions and food products, and methods for their selection. The invention also relates to the use of said bacteria and metabolites for the prevention and/or treatment of gastrointestinal disorders.Type: ApplicationFiled: August 2, 2023Publication date: July 25, 2024Inventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Janne Nikkilä
-
Patent number: 11931385Abstract: A feed additive composition comprising a direct fed microbial (DFM), in combination with a xylanase (e.g. endo-1,4-?-d-xylanase) and a ?-glucanase (and optionally a further fibre degrading enzyme).Type: GrantFiled: July 6, 2021Date of Patent: March 19, 2024Assignee: DUPONT NUTRITION BIOSCIENCES APSInventors: Mai Faurschou Isaksen, Marion Bernardeau, Luis Fernando Romero Millan, Elijah G. Kiarie, Susan Lund Arent, Päivi Nurminen, Sofia Forssten, Daniel Petri, Elizabeth Ann Galbraith, Mari Ellen Davis
-
Publication number: 20230181653Abstract: Provided herein, inter alia, are compositions comprising one or more biologically pure strains of bacteria as well as methods of making and using the same to treat and/or prevent one or more obesity related disorders in a subject m need thereof.Type: ApplicationFiled: April 5, 2021Publication date: June 15, 2023Inventors: Sofia FORSSTEN, Oliver HASSELWANDER, Ashley Ann HIBBERD, Henrik Max JENSEN, Helene M A KANE, Hye-Sook KIM, Ritesh KUMAR, Arthur OUWEHAND, Pia Tuulikki RASINKANGAS, Pierre E ROUVIERE, Buffy L STAHL, Qiong WANG
-
Publication number: 20220354908Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to vaginal cells and producing hydrogen peroxide, their use in probiotic compositions and food products and methods for their selection. The invention also relates to the use of said bacteria, metabolites and probiotic compositions for the prevention and/or treatment of urogenital disorders.Type: ApplicationFiled: January 19, 2022Publication date: November 10, 2022Inventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Inger Mattsby-Baltzer, Björn Andersch
-
Publication number: 20220040241Abstract: A feed additive composition comprising a direct fed microbial (DFM), in combination with a xylanase (e.g. endo-1,4-?-d-xylanase) and a ?-glucanase (and optionally a further fibre degrading enzyme).Type: ApplicationFiled: July 6, 2021Publication date: February 10, 2022Applicant: DUPONT NUTRITION BIOSCIENCES APSInventors: Mai Faurschou Isaksen, Marion Bernardeau, Luis Fernando Romero Millan, Elijah G. Kiarie, Susan Arent Lund, Päivi Nurminen, Sofia Forssten, Daniel Petri, Elizabeth Ann Galbraith, Mari Ellen Davis
-
Publication number: 20200085888Abstract: The present invention relates to bacteria and metabolites thereof that are capable of binding to A, B and/or O blood type antigens or which are acid and/or bile tolerant, their use in probiotic compositions and food products, and methods for their selection. The invention also relates to the use of said bacteria and metabolites for the prevention and/or treatment of gastrointestinal disorders.Type: ApplicationFiled: September 12, 2017Publication date: March 19, 2020Inventors: Heli Putaala, Sofia Forssten, Sampo Lahtinen, Arthur Ouwehand, Jaana Mättö, Harri Mäkivuokko, Janne Nikkilä
-
Publication number: 20190117706Abstract: A feed additive composition comprising a direct fed microbial (DFM), in combination with a xylanase (e.g. endo-1,4-?-d-xylanase) and a ?-glucanase (and optionally a further fibre degrading enzyme), wherein the DFM is selected from the group consisting of an enzyme producing strain; a C5 sugar-fermenting strain; a short-chain fatty acid-producing strain; a fibrolytic, endogenous microflora-promoting strain; or combinations thereof. The DFM may be selected from the group consisting of: Bacillus subtilis AGTP BS3BP5, Bacillus subtilis AGTP BS442, B. subtilis AGTP BS521, B. subtilis AGTP BS918, Bacillus subtilis AGTP BS1013, B. subtilis AGTP BS1069, B. subtilis AGTP 944, B. pumilus AGTP BS 1068 or B.Type: ApplicationFiled: October 2, 2018Publication date: April 25, 2019Inventors: MAI FAURSCHOU ISAKSEN, MARION BERNARDEAU, LUIS FERNANDO ROMERO MLLAN, ELIJAH G. KIARIE, SUSAN ARENT LUND, Päivi NURMINEN, SOFIA FORSSTEN, DANIEL PETRI, ELIZABETH ANN GALBRAITH, MARI ELLEN DAVIS
-
Publication number: 20150216203Abstract: A feed additive composition comprising a direct fed microbial (DFM), in combination with a xylanase (e.g. endo-1,4-?-d-xylanase) and a ?-glucanase (and optionally a further fibre degrading enzyme), wherein the DFM is selected from the group consisting of an enzyme producing strain; a C5 sugar-fermenting strain; a short-chain fatty acid-producing strain; a fibrolytic, endogenous microflora-promoting strain; or combinations thereof. The DFM may be selected from the group consisting of: Bacillus subtilis AGTP BS3BP5, Bacillus subtilis AGTP BS442, B. subtilis AGTP BS521, B. subtilis AGTP BS918, Bacillus subtilis AGTP BS1013, B. subtilis AGTP BS1069, B. subtilis AGTP 944, B. pumilus AGTP BS 1068 or B.Type: ApplicationFiled: August 2, 2013Publication date: August 6, 2015Applicant: DUPONT NUTRITIONAL BIOSCIENCES APSInventors: Mai Faurschou Isaksen, Marion Bernardeau, Luis Fernando Romero Millan, Elijah Gituanjah Kiarie, Susan Lund Arent, Piiivi Helena Nurminen, Sofia Forssten, Daniel Petri, Elizabeth Ann Galbraith